Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Assets
Cash and due from banks	$ 42,083	$ 51,026
Interest-bearing deposits with banks	107,691	197,848
Cash and cash equivalents	149,774	248,874
Restricted investments in bank stocks	26,717	20,232
Securities available-for-sale (amortized cost of $972,138 and $864,920 at December 31, 2025 and 2024, respectively)	952,740	829,711
Loans held for sale, at fair value	6,090	6,614
Loans	4,020,693	3,931,214
Less: Allowance for credit losses	(47,681)	(48,689)
Net loans	3,973,012	3,882,525
Premises and equipment, net	51,029	50,217
Cash surrender value of life insurance	146,994	143,854
Goodwill	69,751	68,106
Other intangible assets, net	37,990	47,765
Accrued interest receivable	21,473	21,058
Deferred tax assets, net	33,931	42,647
Other assets	72,754	79,986
Total assets	5,542,255	5,441,589
Deposits:
Noninterest-bearing	870,906	894,176
Interest-bearing	3,657,868	3,728,920
Total deposits	4,528,774	4,623,096
Securities sold under agreements to repurchase and federal funds purchased	24,542	25,863
FHLB advances and other borrowings	274,701	115,364
Subordinated notes and trust preferred debt	37,122	68,680
Other liabilities	85,581	91,904
Total liabilities	4,950,720	4,924,907
Commitments and contingencies
Shareholders’ Equity
Preferred stock, $1.25 par value per share; 500,000 shares authorized; no shares issued or outstanding	0	0
Common stock, no par value—$0.05205 stated value per share 50,000,000 shares authorized; 19,711,628 shares issued and 19,507,208 outstanding at December 31, 2025; 19,722,640 shares issued and 19,389,967 outstanding at December 31, 2024	1,026	1,027
Additional paid—in capital	424,596	423,274
Retained earnings	186,752	126,540
Accumulated other comprehensive loss	(15,201)	(26,316)
Treasury stock— 204,420 and 332,673 shares, at cost, at December 31, 2025 and 2024, respectively	(5,638)	(7,843)
Total shareholders’ equity	591,535	516,682
Total liabilities and shareholders’ equity	$ 5,542,255	$ 5,441,589